PTCA Drug Coated Balloon (DCB) Catheters Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – ResearchAndMarkets.com

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – ResearchAndMarkets.com




PTCA Drug Coated Balloon (DCB) Catheters Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “PTCA Drug Coated Balloon (DCB) Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering.

The publisher’s Medical Devices sector report, “PTCA Drug Coated Balloon (DCB) Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” provides comprehensive information about the PTCA Drug Coated Balloon (DCB) Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug-coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the PTCA Drug Coated Balloon (DCB) Catheters under development
  • The report reviews details of major pipeline products, which include product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of PTCA Drug Coated Balloon (DCB) Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of PTCA Drug Coated Balloon (DCB) Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 PTCA Drug Coated Balloon (DCB) Catheters Overview

3 Products under Development

3.1 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development

3.2 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Territory

3.3 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Regulatory Path

3.4 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Estimated Approval Date

3.5 PTCA Drug Coated Balloon (DCB) Catheters – Ongoing Clinical Trials

4 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products under Development by Companies

4.1 PTCA Drug Coated Balloon (DCB) Catheters Companies – Pipeline Products by Stage of Development

4.2 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development

5 PTCA Drug Coated Balloon (DCB) Catheters Companies and Product Overview

6 PTCA Drug Coated Balloon (DCB) Catheters- Recent Developments

7 Appendix

Companies Mentioned

  • Aachen Resonance GmbH
  • Acotec Scientific Co Ltd
  • Advanced NanoTherapies Inc
  • B. Braun Interventional Systems Inc
  • Boston Scientific Corp
  • Caliber Therapeutics, Inc.
  • Chansu Vascular Technologies LLC
  • Concept Medical Inc
  • Innova Vascular Inc
  • Jiwei Medical System Ltd
  • Lepu Medical Technology (Beijing) Co Ltd
  • Lifetech Scientific (Shenzhen) Co Ltd
  • M.A. Med Alliance SA
  • Medtronic Plc
  • MicroPort Scientific Corp
  • OrbusNeich
  • Orchestra BioMed Inc
  • QT Vascular Ltd
  • Rontis Hellas SA
  • Shanghai MicroPort Medical Group Co Ltd
  • Shanghai XinZhi Medical Technology Co Ltd
  • Shenzhen Salubris Pharmaceuticals Co Ltd
  • Spectranetics Corp
  • Vascular Nanotransfer Technologies

For more information about this report visit https://www.researchandmarkets.com/r/cfewby

Source: GlobalData

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900